13F HOLDINGS REPORT
Opaleye Management Inc.
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0001493152-25-006852
Total Value
$571.4M
Positions
39
Other Managers
0
Confidential Omitted
No
Holdings (39)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | HARROW HEALTH INC | HROW | 3,990,000 | $133.9M | 23.43% |
| 2 | TG THERAPEUTICS INC | TGTX | 2,260,000 | $68.0M | 11.90% |
| 3 | CODEXIS INC | CDXS | 8,840,000 | $42.2M | 7.38% |
| 4 | ETON PHARMACEUTICALS INC | ETON | 2,852,070 | $38.0M | 6.65% |
| 5 | OCULAR THERAPEUTIX INC | OCUL | 4,342,500 | $37.1M | 6.49% |
| 6 | ARVINAS INC | ARVN | 1,625,000 | $33.6M | 5.89% |
| 7 | RHYTHM PHARMACEUTICALS INC | RYTM | 500,000 | $28.0M | 4.90% |
| 8 | IMMUNOME INC | IMNM | 2,040,000 | $21.7M | 3.79% |
| 9 | LIQUIDIA CORPORATION | LQDA | 1,698,142 | $20.0M | 3.49% |
| 10 | EDGEWISE THERAPEUTICS INC | EWTX | 480,000 | $12.8M | 2.24% |
| 11 | GINKGO BIOWORKS HOLDINGS | DNABW | 1,200,000 | $11.8M | 2.06% |
| 12 | CARGO THERAPEUTICS INC | 14179K101 | 750,000 | $10.8M | 1.89% |
| 13 | PROTARA THERAPEUTICS INC | TARA | 1,825,000 | $9.6M | 1.69% |
| 14 | TREVI THERAPEUTICS INC | TRVI | 2,317,500 | $9.5M | 1.67% |
| 15 | JASPER THERAPEUTICS INC | JSPRW | 400,000 | $8.6M | 1.50% |
| 16 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 325,000 | $8.4M | 1.46% |
| 17 | ACELYRIN INC | 00445A100 | 2,235,000 | $7.2M | 1.26% |
| 18 | NURIX THERAPEUTICS INC | NRIX | 378,500 | $7.1M | 1.25% |
| 19 | XOMA CORP DEL | XOMAP | 250,000 | $6.6M | 1.15% |
| 20 | VAXCYTE INC | PCVX | 75,000 | $6.1M | 1.07% |
| 21 | GOSSAMER BIO INC | GOSS | 11,500,000 | $6.1M | 1.07% |
| 22 | ZENTALIS PHARMACEUTICALS INC | ZNTL | 1,767,500 | $5.4M | 0.94% |
| 23 | BIODESIX INC | BDSX | 3,465,000 | $5.3M | 0.93% |
| 24 | KARYOPHARM THERAPEUTICS INC | KPTI | 6,000,000 | $4.7M | 0.82% |
| 25 | NUVALENT INC | NUVL | 58,500 | $4.6M | 0.80% |
| 26 | GOSSAMER BIO INC | GOSS | 4,490,000 | $4.1M | 0.71% |
| 27 | PROTAGONIST THERAPEUTICS INC | PTGX | 105,000 | $4.1M | 0.71% |
| 28 | ESSA PHARMA INC | 29668H708 | 2,209,998 | $4.0M | 0.69% |
| 29 | ABCELLERA BIOLOGICS INC | ABCL | 965,000 | $2.8M | 0.49% |
| 30 | UROGEN PHARMA LTD | URGN | 220,000 | $2.3M | 0.41% |
| 31 | REZOLUTE INC | RZLT | 465,000 | $2.3M | 0.40% |
| 32 | IMMATICS NV | IMTX | 165,000 | $1.2M | 0.21% |
| 33 | IBIO INC | IBIO | 375,000 | $918,750 | 0.16% |
| 34 | LEXEO THERAPEUTICS INC | LXEO | 130,000 | $855,400 | 0.15% |
| 35 | REGENXBIO Inc | RGNX | 80,000 | $618,400 | 0.11% |
| 36 | VENTYX BIOSCIENCES | 92332V107 | 280,000 | $613,200 | 0.11% |
| 37 | PEPGEN INC | PEPG | 110,000 | $416,900 | 0.07% |
| 38 | STOKE THERAPEUTICS INC | STOK | 25,000 | $275,750 | 0.05% |
| 39 | ADAGIO MED HLDGS INC | 00534B100 | 110,571 | $116,100 | 0.02% |